The Venture Codex Logo

The Venture Codex

Overview

Biotechnology company developing innovative vaccines and immunotherapies.

Total Raised

$28 M

Rounds

4

Links

Verticals

Biotechnology
Health Care
Medical

Investment History

  1. Equity

    Nov 2025

    $15M

  2. Series B

    Jul 2020

    $8M

  3. Equity

    May 2017

    $5M

Team

Anna Sumeray

CEO

Lilli Stergiou

Healthcare